IonQ, Inc. (IONQ) Form 424B5 — Oct 14, 2026
IonQ filed a preliminary 424B5 for a ~$2.0 billion offering of 20.5 million shares plus 100 million Series C Warrants and 29.5 million Pre-funded Warrants, with J.P. Morgan as sole underwriter. Each share (or pre-funded warrant) is sold with two warrants at a combined $40.00 price — a ~15% premium to the prior close of $34.73 — with Series C exercise at $69.46, expiring in seven years. Net proceeds are estimated at $1,988.5 million, earmarked for working capital, general corporate purposes, and strategic acquisitions, notably the pending $1.15 billion all-stock acquisition of Elisity announced October 9, 2026.
Key figures
- Gross Proceeds
- 1999997050
- Offering Price
- 40
- Shares Offered
- 20500000
- Net Proceeds
- $1,988.5 million
- Series CWarrants
- 100000000
- Dilution Per Share
- $34.52
- Pre Funded Warrants
- 29500000
- Warrant Expiration
- October 16, 2033 (7 years)
- Accumulated Deficit
- $2,256.5 million
- Series CExercise Price
- $69.46 per share
- Last Reported Sale Price
- $34.73 (Oct 13, 2026)
- Six Month Operating Loss
- $608.8 million
- Underwriting Discounts
- $10,000,000.00
- Warrant Exercise Shares
- 129500000
- Shares Outstanding Pre Offering
- 408907678
- Shares Outstanding Post Offering
- 429407678
- Shares Outstanding If Warrants Exercised
- 558907678
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.